You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
McKinsey
Mallinckrodt
Moodys
Dow

Last Updated: October 28, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Darinaparsin

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Darinaparsin?

Darinaparsin is an investigational drug.

There have been 12 clinical trials for Darinaparsin. The most recent clinical trial was a Phase 2 trial, which was initiated on March 1st 2016.

The most common disease conditions in clinical trials are Lymphoma, Lymphoma, T-Cell, Peripheral, and Lymphoma, T-Cell. The leading clinical trial sponsors are Ziopharm, Solasia Pharma K.K., and Synex Consulting Korea Ltd.

Recent Clinical Trials for Darinaparsin
TitleSponsorPhase
A Phase 2 Study of SP-02L in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)Solasia Pharma K.K.Phase 2
A Phase 1 Study of SP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL) in KoreaSynex Consulting Korea Ltd.Phase 1
A Phase 1 Study of SP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL) in KoreaSolasia Pharma K.K.Phase 1

See all Darinaparsin clinical trials

Clinical Trial Summary for Darinaparsin

Top disease conditions for Darinaparsin
Top clinical trial sponsors for Darinaparsin

See all Darinaparsin clinical trials

International Patents for Darinaparsin

Drugname Country Document Number Estimated Expiration Related US Patent
Darinaparsin Australia 2005274926 2024-07-16   Start Trial
Darinaparsin Canada 2574032 2024-07-16   Start Trial
Darinaparsin Canada 2777473 2024-07-16   Start Trial
Darinaparsin China 101076533 2024-07-16   Start Trial
Darinaparsin China 104163833 2024-07-16   Start Trial
Darinaparsin China 105777811 2024-07-16   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
McKinsey
Mallinckrodt
Moodys
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.